SCHEMBL7035698

SCHEMBL7035698

Cc1cccc2nc(-c3ccc(-c4ccc(C(=O)O)cc4)o3)[nH]c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 1/20 0.46
PDE1A P54750 1/20 0.46
PDE1B Q01064 1/20 0.46
PDE1C Q14123 1/20 0.46
KMT2A Q03164 6/20 0.45
KDM4E B2RXH2 6/20 0.45
ALDH1A1 P00352 4/20 0.45
HPGD P15428 3/20 0.45
NR1H4 Q96RI1 1/20 0.43
POLB P06746 5/20 0.41
TDP1 Q9NUW8 5/20 0.41
MEN1 O00255 4/20 0.41
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
MAPT P10636 3/20 0.41
RECQL P46063 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 1/20 0.41
THRB P10828 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7037098 0.87 ALDH1A1 (0.51) KMT2AKDM4EALDH1A1HPGDPOLB
SCHEMBL7945644 0.86 KDM4E (0.59) KMT2AKDM4EALDH1A1HPGDNR1H4
SCHEMBL7040235 0.81 MGAM (0.52) PDE5APDE1APDE1BPDE1CKMT2A
SCHEMBL7035502 0.80 KDM4E (0.71) PDE5APDE1APDE1BPDE1CKMT2A
SCHEMBL7036871 0.76 KDM4E (0.48) PDE5APDE1APDE1BPDE1CKMT2A
SCHEMBL7041702 0.76 MMP2 (0.54) KMT2AKDM4EALDH1A1HPGDTDP1
SCHEMBL12713529 0.72 MMP2 (0.64) KMT2AKDM4EALDH1A1HPGDPOLB
SCHEMBL7943519 0.71 KDM4E (0.61) KMT2AKDM4EALDH1A1HPGDMEN1
SCHEMBL7039869 0.71 CHEK2 (0.53) PDE5APDE1APDE1BPDE1CKMT2A
SCHEMBL7038187 0.71 CHEK2 (0.62) KMT2AKDM4EALDH1A1HPGDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030104473-A1 Common ligand mimics: benzimidazoles TRIAD THERAPEUTICS, INC. 2003-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030104473-A1 Common ligand mimics: benzimidazoles BID, LIFR, FGFR3 PDE5A 4252/4885PDE1A 763/4885PDE1B 759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.